SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

GRLS.MC (GRLS.MC) News

Track canonical SquawkNews coverage tagged to GRLS.MC, GRLS.MC. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol GRLS.MC Asset market Sector Markets 90 days 1 Updated Sep 21, 2026, 08:03 AM UTC Open live news feed
M Grifols Alzheimer's drug AMBAR shows 61% reduction in disease progression Grifols strengthened evidence for its AMBAR program with new real-world evidence data showing a 61% reduction in disease progression in patients with mild to moderate Alzheimer's disease compared with untreated patients. EQUITY | Sep 21, 2026, 08:03 AM UTC